Search
for
Sort by
Research 361–390 of 1000+
- Mycobacterial 65,000 MW heat-shock protein shares a carboxy-terminal epitope with human epidermal cytokeratin 1/2.
- Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness
- Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
- Toxicological Studies on Procyanidin B-2 for Extern?al Application as a Hair Growing Agent
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- State-dependent signaling by Ca<sub>v</sub>1.2 regulates hair follicle stem cell function
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- 5alpha-reductase 2 inhibition impairs brain defeminization of male rats: Reproductive aspects
- The first clinical trial of topical application of procyanidin B‐2 to investigate its potential as a hair growing agent
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- The Pharmacokinetics of 2.5- to 10-mg Oral Doses of Minoxidil in Healthy Volunteers
- Acute telogen effluvium associated with SARS-CoV-2 infection
- Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin
- Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine
- Melanocortin receptor type 2 (MC2R, ACTH receptor) expression in patients with alopecia areata
- Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-<i>N</i>-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors
- Pmg-1 and Pmg-2 constitute a novel family of KAP genes differentially expressed during skin and mammary gland development
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- Re-epithelialization of the skin following CO 2 laser resurfacing
- The role of ketoconazole 2% shampoo in the treatment and prophylactic management of dandruff
- Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors
- Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis
- Expression patterns of the glial cell line–derived neurotrophic factor, neurturin, their cognate receptors GFRα-1, GFRα-2, and a common signal transduction element c-Ret in the human skin hair follicles
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- The Bio-Safety Concerns of Three Domestic Temporary Hair Dye Molecules: Fuchsin Basic, Victoria Blue B and Basic Red 2
- Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
- Minoxidil induced hypertrichosis in a 2 year-old child
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Timely Wound Healing Is Dependent on Endothelial but Not on Hair Follicle Stem Cell Toll-Like Receptor 2 Signaling